CCRNHealthcare · Medical Care FacilitiesCCRN Stock Forecast: Cross Country Healthcare, Inc. Price Predictions for 2026-2027
The 7 Wall Street analysts covering Cross Country Healthcare, Inc. hold a median 12-month price target of $13 — +0.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 94 of 100 as at 21 July 2026 — among the strongest tenth. The factors read stronger than the Street's target implies. That gap is the story on this page.
CCRN stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Cross Country Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (98): Reported profit is backed by cash, and the company is not expanding recklessly.
Quality (53): Profits are thin or unreliable for the size of the business, or they are not turning into cash.
The rank is the raw material. Whether the rules would actually own Cross Country Healthcare, Inc. — and when they’d sell — is the membership.
CCRN stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on CCRN, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
The green dot is the last close — the median target sits 0.0% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 8 June 2026 | Barrington Research | Maintains | Market Perform | $13 |
| 8 June 2026 | Barrington Research | Maintains | Market Perform | — |
| 11 May 2026 | Truist Securities | Maintains | Hold | — |
| 8 May 2026 | Benchmark | Downgrade | Hold | — |
| 7 May 2026 | Wedbush | Downgrade | Neutral | — |
| 19 Mar 2026 | Wedbush | Upgrade | Outperform | — |
| 5 Mar 2026 | Benchmark | Upgrade | Buy | — |
| 3 Feb 2026 | Wedbush | Initiates | Neutral | — |
| 9 Dec 2025 | UBS | Maintains | Neutral | — |
| 17 June 2025 | Barrington Research | Maintains | Market Perform | — |
| 13 May 2025 | UBS | Maintains | Neutral | — |
| 14 Mar 2025 | Barrington Research | Maintains | Market Perform | — |
| 6 Feb 2025 | JMP Securities | Reiterates | Market Perform | — |
| 10 Dec 2024 | Barrington Research | Downgrade | Market Perform | — |
| 5 Dec 2024 | Truist Securities | Maintains | Hold | — |
| 7 Nov 2024 | Benchmark | Maintains | Buy | — |
| 21 Oct 2024 | Truist Securities | Maintains | Hold | — |
| 8 Aug 2024 | Barrington Research | Maintains | Outperform | — |
| 1 Aug 2024 | Truist Securities | Maintains | Hold | — |
| 6 May 2024 | Barrington Research | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
CCRN analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Cross Country Healthcare, Inc. (CCRN) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 48.3×
- Price / sales
- 0.4×
- Price / book
- 1.3×
- EV / EBITDA
- 23.0×
Cheaper than 16% of US stocks
Cheaper than 85% of US stocks
Cheaper than 62% of US stocks
Cheaper than 13% of US stocks
- Revenue growth (YoY)
- −17.8%
- Earnings growth (YoY)
- −17.8%
- Gross margin
- 19.7%
- Operating margin
- −0.8%
- Net margin
- −9.8%
Higher than 12% of US stocks
Higher than 21% of US stocks
Higher than 22% of US stocks
Higher than 34% of US stocks
Higher than 20% of US stocks
- Return on equity
- −27.0%
- Return on assets
- −0.1%
- Dividend yield
- —
Higher than 28% of US stocks
Higher than 43% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
CCRN vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CCRN appears on the weeks it earns a place.
Frequently asked questions about CCRN stock
What is the CCRN stock price forecast for 2026-2027?
The 7 Wall Street analysts covering Cross Country Healthcare, Inc. have a median 12-month price target of $13, with estimates ranging from $10 to $13. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is CCRN stock a buy right now?
Of the 7 analysts covering Cross Country Healthcare, Inc., 0 rate it a Buy, 7 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Cross Country Healthcare, Inc. 94 out of 100 across roughly 4,600 US stocks as at 21 July 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank CCRN?
As at 21 July 2026, Cross Country Healthcare, Inc. ranks 94 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (98 of 100).
Will CCRN stock go up?
No one can know that. What the data says: the median 12-month target from 7 analysts implies +0.0% from the last close, and Ticker Nerd's factor model ranks Cross Country Healthcare, Inc. 94 out of 100 as at 21 July 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the CCRN stock forecast for 2030?
No analyst covering Cross Country Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CCRN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $13 over the next 12 months.
What does Cross Country Healthcare, Inc. do?
Cross Country Healthcare Inc. is a leading provider of workforce solutions to the healthcare sector in the United States.
About Cross Country Healthcare, Inc.
Cross Country Healthcare Inc. is a leading provider of workforce solutions to the healthcare sector in the United States. Its primary function is to offer staffing services including travel nurse and allied health staffing, per diem and permanent placement, as well as workforce management solutions to hospitals and healthcare facilities nationwide. This company plays a vital role in ensuring healthcare facilities can maintain optimal staffing levels, enhancing patient care and healthcare delivery across various settings. Cross Country Healthcare Inc. has an impactful presence in areas such as nursing, emergency medicine, and allied health, addressing the critical demand for healthcare professionals. By partnering with healthcare providers and professionals, Cross Country Healthcare actively contributes to mitigating staffing shortages and improving healthcare accessibility. Established in Boca Raton, Florida, the company leverages its industry expertise and expansive network to deliver comprehensive staffing solutions, making it a crucial component of the healthcare industry’s operational framework.
CEO Mr. John A. Martins · 7,890 employees · United States · https://www.crosscountry.com